# US 2015/0088222 A1 · Ingestible, electrical device for stimulating tissues in a gastrointestinal tract of an organism

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0088222 A1
- Document ID: US20150088222A1
- Status: Published application
- Kind: A1
- Application number: 14/397,749
- Filed: 2013-04-30
- Published: 2015-03-26
- Earliest claimed: 2012-04-30
- Assignees: Carnegie Mellon University
- Applicants: Carnegie Mellon University
- Inventors: Christopher J. Bettinger
- Web page: https://patentgrep.com/patent/US20150088222A1

## CPC

- A61N 1/36007: {of urogenital or gastrointestinal organs, e.g. for incontinence control}
- A61N 1/0509: {Stomach and intestinal electrodes}
- A61N 1/18: Applying electric currents by contact electrodes
- A61N 1/3787: {from an external energy source}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

In one aspect, an ingestible, electrical device, comprises one or more electrodes comprising a biocompatible conducting material and a biocompatible insulating material; a generator connected to the one or more electrodes; and an outer casing enclosing the one or more electrodes and the generator, the outer casing configured to dissolve in an aqueous environment of the organism; wherein the one or more electrodes have a first form factor when enclosed in the outer casing and a second form factor following a dissolution of the outer casing, the first form factor is a form factor that is collapsed an increased amount relative to an amount that the second form factor is collapsed, and the second form factor is a form factor that is collapsed a decreased amount relative to an amount that the first form factor is collapsed.

## Claims

### Claim 1

An ingestible, electrical device, comprising:
one or more electrodes comprising a biocompatible conducting material and a biocompatible insulating material;
a generator connected to the one or more electrodes, with the generator being configured to deliver one or more of a current or a voltage across the one or more electrodes to stimulate one or more internal cells of an organism that ingests the ingestible, electrical device; and
an outer casing enclosing the one or more electrodes and the generator, the outer casing configured to dissolve in an aqueous environment of the organism;
wherein the one or more electrodes have a first form factor when enclosed in the outer casing and a second form factor following a dissolution of the outer casing, wherein the first form factor is a form factor that is collapsed an increased amount relative to an amount that the second form factor is collapsed, and wherein the second form factor is a form factor that is collapsed a decreased amount relative to an amount that the first form factor is collapsed.

### Claim 2 (depends on 1)

The ingestible, electrical device of claim 1, wherein the one or more electrodes comprise a complementary anode cathode pair.

### Claim 3 (depends on 1)

The ingestible, electrical device of claim 1, where the biocompatible conducting material comprises at least one of a bioinert metal or a conducting polymer.

### Claim 4 (depends on 3)

The ingestible, electrical device of claim 3, wherein the bioinert metal comprises at least one of copper, gold, magnesium, silver, platinum, or zinc.

### Claim 5 (depends on 1)

The ingestible, electrical device of claim 1, wherein the biocompatible insulating material comprises a bioexcretable copolymer.

### Claim 6 (depends on 5)

The ingestible, electrical device of claim 5, wherein the bioexcretable copolymer comprises at least one of polyester, polyanhydride, polyamide, polyether, polyphosphoester, polyorthoester, poly(ε-caprolactone) (PCL), or poly(ethylene glycol) (PEG).

### Claim 7 (depends on 1)

The ingestible, electrical device of claim 1, wherein the generator comprises a water-activated battery comprising one or more biocompatible materials.

### Claim 8 (depends on 1)

The ingestible, electrical device of claim 1, wherein the generator comprises a receiver coil and a rectifying circuit, each of the receiver coil and the rectifying circuit comprising one or more of a biodegradable material and a bioinert metal, the receiver coil configured to receive a near-field radio frequency signal, and the rectifying circuit configured to convert energy from the near-field radio frequency signal into the one or more of the current or the voltage.

### Claim 9 (depends on 1)

The ingestible, electrical device of claim 1, wherein the generator comprises one or more fuel cells.

### Claim 10 (depends on 1)

The ingestible, electrical device of claim 1, wherein the generator is configured to provide up to 0.1 mA of current for up to 90 minutes.

### Claim 11 (depends on 1)

The ingestible, electrical device of claim 1, wherein the outer casing comprises at least one of gelatin, synthetic alphahydroxy polymer, crosslinked carbohydrate, polyester, polyanhydride, polyamide, polyether, polyphosphoester, polyorthoester, poly(ε-caprolactone) (PCL), or poly(ethylene glycol) (PEG).

### Claim 12 (depends on 1)

The ingestible, electrical device of claim 1, wherein a timing of the dissolution of the outer casing is based on a thickness of and a degree of crosslinking within a material of the outer casing.

### Claim 13 (depends on 1)

The ingestible, electrical device of claim 1, wherein the ingestible, electrical device is an electrical device that stimulates one or more internal cells of a gastrointestinal tract of the organism.

### Claim 14 (depends on 1)

The ingestible, electrical device of claim 1, wherein the first form factor of the one or more electrodes is formed by configuring the one or more electrodes into a planar geometry and straining the one or more electrodes equibiaxially during deposition of the bioinert metal to promote thin film metallic buckling of the one or more electrodes.

### Claim 15

A method performed by an ingestible, electrical device, comprising:
following a dissolution of an outer casing of the ingestible, electrical device,
expanding a form factor of one or more electrodes included in the ingestible, electrical device;
wherein at least one of the one or more electrodes comprises a biocompatible conducting material and a biocompatible insulating material; and
wherein the dissolution occurs in an organism that ingests the ingestible, electrical device;
activating, based on exposure to an aqueous environment in the organism, a generator of the ingestible, electrical device, the generator being connected to the one or more electrodes;
following activation of the generator,
delivering one or more of a current or a voltage across the one or more electrodes of the ingestible, electrical device;
stimulating, based on delivery of the one or more of the current or the voltage, one or more internal cells of the organism that ingests the ingestible, electrical device; and
ceasing to deliver the one or more of the current or the voltage across the one or more electrodes after a predetermined time;
wherein the ingestible, electrical device is configured to break down following a cease in delivery of the one or more of the current or the voltage.

### Claim 16 (depends on 15)

The method of claim 15, further comprising:
causing, based on stimulating, a decrease in an amount of intestinal motility in the organism relative to an amount of intestinal motility in the organism prior to stimulation.

### Claim 17 (depends on 15)

The method of claim 15, wherein the ingestible, electrical device is an electrical device that stimulates one or more internal cells of a gastrointestinal tract of the organism.

### Claim 18 (depends on 15)

The method of claim 15, wherein the biocompatible conducting material comprises at least one of a bioinert metal or a conducting polymer.

### Claim 19 (depends on 18)

The method of claim 18, wherein the bioinert metal comprises at least one of copper, gold, magnesium, silver, platinum, or zinc.

### Claim 20 (depends on 15)

The method of claim 15, wherein the biocompatible insulating material comprises a bioexcretable copolymer.

### Claim 21 (depends on 20)

The method of claim 20, wherein the bioexcretable copolymer comprises at least one of polyester, polyanhydride, polyamide, polyether, polyphosphoester, polyorthoester, poly(ε-caprolactone) (PCL) or poly(ethylene glycol) (PEG).

### Claim 22 (depends on 15)

The method of claim 15, wherein the generator comprises a water-activated battery comprising biocompatible materials.

### Claim 23 (depends on 15)

The method of claim 15, wherein the generator comprises a receiver coil and a rectifying circuit, each of the receiver coil and the rectifying circuit comprising one or more of a biodegradable material and a bioinert metal, the receiver coil configured to receive a near-field radio frequency signal, and the rectifying circuit configured to convert energy from the near-field radio frequency signal into the one or more of the current or the voltage.

### Claim 24 (depends on 15)

The method of claim 15, wherein the generator comprises one or more fuel cells.

### Claim 25 (depends on 15)

The method of claim 15, wherein the generator is configured to provide up to 0.1 mA of current for up to 90 minutes.

### Claim 26 (depends on 15)

The method of claim 15, wherein the outer casing comprises at least one of a gelatin material, a synthetic alphahydroxy polymer, a crosslinked carbohydrate, polyester, polyanhydride, polyamide, polyether, polyphosphoester, polyorthoester, poly(ε-caprolactone) (PCL), or poly(ethylene glycol) (PEG).

### Claim 27 (depends on 15)

The method of claim 15, wherein a timing of the dissolution of the outer casing is based on a thickness of and a degree of crosslinking within a material of the outer casing.

### Claim 28

A gastroelectrical stimulation (GES) device, comprising:
one or more electrodes comprising gold deposited on a poly(ε-caprolactone) (PCL) and poly(ethylene glycol) (PEG) copolymer, the one or more electrodes configured to stimulate one or more internal cells of an organism that ingests the GES device to cause a decrease in an amount of intestinal motility in the organism relative to an amount of intestinal motility in the organism prior to stimulation;
a water-activated battery comprising one or more biocompatible materials, the water-activated battery connected to the one or more electrodes, with the water-activated battery being configured to deliver a current of up to 0.1 mA for up to 90 minutes across the one or more electrodes to stimulate the one or more internal cells of the organism that ingests the GES device; and
an outer casing comprising gelatin material in a capsule form, the outer casing enclosing the one or more electrodes and the water-activated battery, the outer casing configured to dissolve in an aqueous environment of the organism, with a timing of a dissolution of the outer casing based on a thickness and a degree of crosslinking within the gelatin material;
wherein the electrodes have a first form factor when enclosed in the outer casing and a second form factor following the dissolution of the outer casing, wherein the first form factor is a form factor with an decreased amount of expansion relative to an amount of expansion of the second form factor, and wherein the second form factor is a form factor with an increased amount of expansion relative to an amount of expansion of the first form factor.
